Isabel Torgal

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Endometrial cancer is the most frequent gynecological malignancy in developed world. Cancer stem cells (CSC) are recognized as a small proportion of cells among the tumor cell population that are capable of self-renewal, aberrant differentiation, and escape homeostasis. This review aims to systematize the existing evidence of CSC of endometrial cancer and(More)
Endometrial stromal tumor is a rare mesenchymal uterine tumor. We report the case of a patient with endometrial stromal sarcoma and concomitant bilateral endometrioid adenocarcinoma of the ovary in the context of pelvic endometriosis. The patient underwent a complete cytoreduction including total hysterectomy and bilateral adnexectomy, pelvic(More)
In vivo pulmonary metastatic profile of breast cancer cell lines expressing hormonal receptors versus triple negative Breast cancer metastized to lungs is a challenge considering clinical management and molecular processes. The interaction between tumor cells and lung environment as well as the influence of hormonal receptor (HR) are a question of debate.(More)
Breast cancer patients are stratified in 3 groups: expressing hormonal receptors (HR), which respond to therapies targeting estrogen receptors; HER2+, candidates to trastuzumab; and triple negative (TN), for which, despite its more aggressive clinical behavior, chemotherapy is therapy available. In vitro studies proved that cells subjected to specific(More)
  • 1